Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02107937
Recruitment Status : Recruiting
First Posted : April 8, 2014
Last Update Posted : November 14, 2018
Sponsor:
Information provided by (Responsible Party):
Sotio a.s.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : December 2023